BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression

MLA

Hengrui Zhu, et al. “BET Bromodomain Inhibition Promotes Anti-Tumor Immunity by Suppressing PD-L1 Expression.” Cell Reports, vol. 16, no. 11, Sept. 2016, pp. 2829–37. EBSCOhost, https://doi.org/10.1016/j.celrep.2016.08.032.

APA

Hengrui Zhu, Fee Bengsch, Nikolaos Svoronos, Melanie R. Rutkowski, Benjamin G. Bitler, Michael J. Allegrezza, Yuhki Yokoyama, Andrew V. Kossenkov, James E. Bradner, Jose R. Conejo-Garcia, & Rugang Zhang. (2016). BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression. Cell Reports, 16(11), 2829–2837. https://doi.org/10.1016/j.celrep.2016.08.032

Chicago

Hengrui Zhu, Fee Bengsch, Nikolaos Svoronos, Melanie R. Rutkowski, Benjamin G. Bitler, Michael J. Allegrezza, Yuhki Yokoyama, et al. 2016. “BET Bromodomain Inhibition Promotes Anti-Tumor Immunity by Suppressing PD-L1 Expression.” Cell Reports 16 (11): 2829–37. doi:10.1016/j.celrep.2016.08.032.